Greenbrook TMS Q4 2023 Earnings Report $0.01 -0.01 (-35.29%) (As of 12/20/2024 05:18 PM ET) Earnings History Greenbrook TMS EPS ResultsActual EPS-$0.35Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AGreenbrook TMS Revenue ResultsActual Revenue$17.50 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AGreenbrook TMS Announcement DetailsQuarterQ4 2023Date4/25/2024TimeN/AConference Call ResourcesGBNHF Earnings History We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Greenbrook TMS Earnings HeadlinesGREENBROOK TMS REPORTS THIRD QUARTER OPERATIONAL AND FINANCIAL RESULTSNovember 29, 2024 | prnewswire.comGREENBROOK RECEIVES FINAL COURT APPROVAL FOR ARRANGEMENT WITH NEURONETICSNovember 15, 2024 | prnewswire.comWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.December 22, 2024 | Behind the Markets (Ad)GREENBROOK SHAREHOLDERS APPROVE ARRANGEMENT WITH NEURONETICSNovember 11, 2024 | prnewswire.comGREENBROOK ANNOUNCES CONVERSION OF SUBORDINATED CONVERTIBLE NOTESOctober 3, 2024 | prnewswire.comGREENBROOK TMS REPORTS SECOND QUARTER OPERATIONAL AND FINANCIAL RESULTSAugust 13, 2024 | prnewswire.comSee More Greenbrook TMS Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Greenbrook TMS? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Greenbrook TMS and other key companies, straight to your email. Email Address About Greenbrook TMSGreenbrook TMS (NASDAQ:GBNHF), together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared neurostimulation therapy for the treatment of major depressive disorder and other mental health disorders. The company also offers Spravato, an esketamine nasal spray; and other treatment modalities for the treatment of depression and related psychiatric services. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.View Greenbrook TMS ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles History Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of Earnings Upcoming Earnings Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
